A new, nonprofit advocacy and education foundation?The Foundation for Women and Girls with Blood Disorders (FWGBD)?seeks to promote correct diagnosis and optimal management of conditions such as von Willebrand disease, thrombophilia, sickle cell disease, and anemias at every stage of life. MORE
A new, nonprofit advocacy and education foundation-The Foundation for Women and Girls with Blood Disorders (FWGBD)-seeks to promote correct diagnosis and optimal management of conditions such as at every stage of life.
The foundation, based in Montclair, New Jersey, was established by experts in blood disorders and women’s health to provide a multifaceted array of educational programs for healthcare providers. A December 1 Webinar, Women and Bleeding Disorders, will officially launch the foundation and its full Web site. In the meantime, providers can go to a preview Web site, www.fwgbd.org, to sign up for news and information and reserve a place for the Webinar and a satellite symposium on December 9, preceding the 53rd American Society of Hematology Annual Meeting and Exposition in San Diego. Both CME-accredited programs are jointly sponsored by Duke University School of Medicine and FWGBD.
“Women and girls with blood disorders face unique issues and medical consequences at different stages of life,” says Andra James, MD, MPH, a founder of the FWGBD and the Women’s Hemostasis and Thrombosis Clinic at Duke University Medical Center (Durham, North Carolina). “These issues often get buried and fragmented in various sources. The purpose of the foundation is to create a single site and source where physicians and healthcare providers can go to obtain information.”
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More
Breast arterial calcifications linked to cardiovascular disease risk
September 12th 2024In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 23% of patients with breast arterial calcifications on a mammogram had atherosclerotic cardiovascular disease, vs 13.9% without.
Read More
Cognitive behavioral therapy could help mitigate sexual concerns during menopause
September 11th 2024A new study presented at the 2024 Annual Meeting of the Menopause Society found cognitive behavioral therapy can effectively address sexual concerns during menopause, improving overall well-being.
Read More